The natural small molecule compound: 2，3，5，6-tetramethylpyrazine (TMP)， is a major component of the Chinese medicine ， which has wide clinical applications in dilating blood vessels， inhibiting platelet aggregation and treating thrombosis. Recent work suggests that TMP is also an antitumour agent. Despite its chemotherapeutic potential， the mechanism(s) underlying TMP action are unknown. Herein， we demonstrate that TMP binds to mitochondrial transcription factor A (TFAM) and blocks its degradation by the mitochondrial Lon protease. TFAM is a key regulator of mtDNA replication， transcription and transmission. Our previous work showed that when TFAM is not bound to DNA， it is rapidly degraded ... More
The natural small molecule compound: 2，3，5，6-tetramethylpyrazine (TMP)， is a major component of the Chinese medicine ， which has wide clinical applications in dilating blood vessels， inhibiting platelet aggregation and treating thrombosis. Recent work suggests that TMP is also an antitumour agent. Despite its chemotherapeutic potential， the mechanism(s) underlying TMP action are unknown. Herein， we demonstrate that TMP binds to mitochondrial transcription factor A (TFAM) and blocks its degradation by the mitochondrial Lon protease. TFAM is a key regulator of mtDNA replication， transcription and transmission. Our previous work showed that when TFAM is not bound to DNA， it is rapidly degraded by the ATP-dependent Lon protease， which is essential for mitochondrial proteostasis. In cultured cells， TMP specifically blocks Lon-mediated degradation of TFAM， leading to TFAM accumulation and subsequent up-regulation of mtDNA content in cells with substantially low levels of mtDNA. protease assays show that TMP does not directly inhibit mitochondrial Lon， rather interacts with TFAM and blocks degradation. Pull-down assays show that biotinylated TMP interacts with TFAM. These findings suggest a novel mechanism whereby TMP stabilizes TFAM and confers resistance to Lon-mediated degradation， thereby promoting mtDNA up-regulation in cells with low mtDNA content.
